Brief Report: Miscarriages in Female Rheumatoid Arthritis Patients: Associations With Serologic Findings, Disease Activity, and Antirheumatic Drug Treatment

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1738-1743

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 21, Iss. 1, 2018-01 ,pp. : 170-178

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease‐modifying anti‐rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 4, 2015-05 ,pp. : 421-432

John Wiley & Sons Inc

Access to resources Recommend Favorite

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis

By Turkstra E.   Ng S.-K.   Scuffham P.A.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1885-1897

Informa Healthcare

Access to resources Recommend Favorite

Safety and retention of combination triple disease‐modifying anti‐rheumatic drugs in new‐onset rheumatoid arthritis

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 12, 2015-12 ,pp. : 1266-1273

John Wiley & Sons Inc

Access to resources Recommend Favorite